- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/55 - Protease inhibitors
Patent holdings for IPC class A61K 38/55
Total number of patents in this class: 667
10-year publication summary
45
|
52
|
36
|
47
|
41
|
38
|
52
|
53
|
36
|
13
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
CSL Behring GmbH | 350 |
18 |
The Johns Hopkins University | 5377 |
11 |
Takeda Pharmaceutical Company Limited | 2961 |
11 |
Entera Bio Ltd. | 31 |
11 |
Mondobiotech Laboratories AG | 311 |
11 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
10 |
The Regents of the University of California | 18943 |
9 |
Daiichi Sankyo Company, Limited | 1829 |
8 |
Massachusetts Eye and Ear Infirmary | 348 |
8 |
Oramed Ltd. | 25 |
8 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
7 |
The General Hospital Corporation | 4517 |
6 |
Société des Produits Nestlé S.A. | 9672 |
5 |
Centre National de La Recherche Scientifique | 9632 |
5 |
University of Florida Research Foundation, Inc. | 3883 |
5 |
ViroPharma Biologics LLC | 59 |
5 |
Hoffmann-La Roche Inc. | 3060 |
4 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
4 |
The Trustees of Columbia University in the City of New York | 3440 |
4 |
Mayo Foundation for Medical Education and Research | 2981 |
4 |
Other owners | 513 |